Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 3Glioma 2Diffuse Intrinsic Pontine Glioma 2Astrocytoma 2Optic Nerve Glioma 1Oligodendroglioma 1Medulloblastoma 1Liver Cirrhosis 1Gliosarcoma 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Brain Stem Neoplasms 1

Interventions

Carboplatin 8Filgrastim 6Temozolomide 5Etoposide 5etoposide phosphate 3Vincristine 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Melphalan 2Magnetic Resonance Spectroscopy 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Cyproheptadine 2Cyclophosphamide 2Busulfan 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trioctyl phosphine oxide 1sodium thiosulfate 1sargramostim 1gallium Ga 68 dotatate 1fluorodopa F 18 1antineoplaston AS 2-1 1antineoplaston A10 1Transplantation 1Topotecan 1Thiotepa 1Stem Cell Transplantation 1Radiotherapy, Intensity-Modulated 1Photochemotherapy 1Perfusion Magnetic Resonance Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Optic Nerve Glioma × Mebendazole × Clear all
NCT01837862 2024-07-05

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas

Northwell Health

Phase 1/2 Completed
36 enrolled
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Gliosarcoma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡